Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Articles — Page 1611
Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Could Buying Today Life? What XRP Investors Should Know
Is it possible that a modest XRP investment today could change your financial future? This guide weighs the odds, out...
Leveraged ETFs Among Market's: Are They Too Aggressive for Investors?
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
Million Arcellx Sale Follows Stock Drop as Rival Emerges
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
Celcuity Stock Soars 700% After Major Investor Buy
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Betting Against Wall Street: The Inverse ETF Surge
Investors are increasingly betting against Wall Street with inverse ETFs. This article explains how these funds work,...
Where Will Rocket Stock Go in 10 Years? An Investor Guide
Investing in space stocks is no longer a sci‑fi dream. This guide breaks down where will rocket stock likely head in ...
Counting Home Equity Fund? Why It's Risky for Retirement
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
Cognex Stock Sell After Director Dump: Buy or Sell?
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...